MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-25-0002375
Valentis Laboratories Private Limited - pharma in Sangareddy, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹160.96 Cr
▲ 135% YoY
Net profit · FY 2025
₹4.03 Cr
Net margin 2.5%
EBITDA · FY 2025
₹12.68 Cr
EBITDA margin 7.9%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹3.1 Cr
Issued & subscribed
Open charges
₹30.64 Cr
Satisfied ₹8.99 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
108
Provident fund records
About Valentis Laboratories Private Limited
Data last updated:
Valentis Laboratories Private Limited is a private limited company based in Sangareddy, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 May 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG1999PTC031736. Its GSTIN is 36AAECS3574Q1ZN (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹3.1 Cr. It was formerly known as Valentis Pharma Private Limited and Netmatrix Srichaitanya Chlorides Limited. It is led by directors including Sriramakrishna Durgaprasad Pratiwada (Managing Director) and Devarapu Phani Deep.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 29 30 31 32 39 40 41 42 Phase II Ida, Pashamylaram Patancheru Sangareddy, Telangana, India – 502307.
As per the financials filed for FY 2025, the company reported a revenue of ₹160.96 Cr, a growth of 135% compared to the previous year. For the same year it recorded a net profit of ₹4.03 Cr (net margin 2.5%) and EBITDA of ₹12.68 Cr (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 12% over five years.
The company has about 108 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹30.64 Cr and satisfied charges of ₹8.99 Cr on record. Court records list 51 cases involving the company, including 25 filed by the company and 26 filed against it; 30 cases are pending. The company has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹40 Lakh; the latest was in March 2023. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Calyx Chemicals and Pharmaceuticals Limited with revenue of ₹163.62 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2022, listing 181 overdue payments to 63 micro and small suppliers.
Valentis Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-25-0002375). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website valentislabs.com.
Company details
CIN U24110TG1999PTC031736
Registration Number 031736
Incorporation Date 19 May 1999
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-25-0002375
Name history
Valentis Laboratories has undergone 5 name changes throughout its history. The current legal name is Valentis Laboratories Private Limited.
| Company Name | Status |
|---|---|
| Valentis Laboratories Private Limited | Current |
| Valentis Pharma Private Limited | Previous |
| Netmatrix Srichaitanya Chlorides Limited | Previous |
| Netmatrix Srichaitanya Chlorides Private Limited | Previous |
| Srichaitanya Chlorides Private Limited | Previous |
| Srichaitanya Chlorides Limited | Previous |
CIN history
Valentis Laboratories has one previous CIN (Corporate Identification Number): U24110AP1999PTC031736. The current CIN is U24110TG1999PTC031736, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1999PTC031736 | Current |
| U24110AP1999PTC031736 | Previous |
Key People
Sriramakrishna Durgaprasad Pratiwada Managing Director Devarapu Phani Deep Director Ravi Teja Prativada Director Recognitions & Rankings of Valentis Laboratories
Contact details
Valentis Laboratories Private Limited's registered office is in Sangareddy, Telangana. Its website is valentislabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 29 30 31 32 39 40 41 42 Phase II Ida, Pashamylaram Patancheru Sangareddy, Telangana, India – 502307
- IndustryPharma, API Manufacturers
To see the full contact details of Valentis Laboratories Private Limited, buy the company report.
Comprehensive company report
Valentis Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Valentis Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Valentis Laboratories Private Limited, buy the company report.
Financials of Valentis Laboratories Private Limited
FY 2025 filings availableValentis Laboratories Private Limited reported revenue of ₹160.96 Cr (up 135% YoY) for FY 2025.
Revenue · FY 2025
₹160.96 Cr ▲ 135%
Net profit · FY 2025
₹4.03 Cr margin 2.5%
EBITDA · FY 2025
₹12.68 Cr margin 7.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 135%
3 years · compounded
▲ 26%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 85%
3 years · compounded
▲ 32%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 135% growth in the latest year. EBITDA rose 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Valentis Laboratories Private Limited, buy the company report.
Board of directors of Valentis Laboratories Private Limited
Valentis Laboratories has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devarapu Phani Deep | Director | 05 Apr 2018 | 8 Years 6 Months | Current |
| Ravi Teja Prativada | Director | 14 Mar 2023 | 3 Years 7 Months | Current |
| Pratiwada Venkata Chaitanya Prasad Also directs: Gingurthy Minerals LLP, Kleem Materials LLP, Terratech Intermediates (India) Private Limited and 2 more | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
| Sriramakrishna Durgaprasad Pratiwada Also directs: Gingurthy Minerals LLP, Kleem Materials LLP, Terratech Intermediates (India) Private Limited and 3 more | Managing Director | 19 May 2009 | 17 Years 5 Months | Current |
| Partiwada Roja Rani | Director | 01 Apr 2000 | 26 Years 6 Months | Current |
Peer comparison
Valentis Laboratories Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Calyx Chemicals and Pharmaceuticals Limited | ₹163.62 Cr (FY 2024) | -21.0% | Thane, Maharashtra, India | |||
| S.V. Labs Private Limited | ₹162.99 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Vasista Life Sciences Private Limited | ₹162.88 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Syntho Chirals Private Limited | ₹162.38 Cr (FY 2024) | 23.0% | Hyderabad, Telangana, India | |||
| Vivin Drugs & Pharmaceuticals Private Limited | ₹161.52 Cr (FY 2023) | -25.0% | Hyderabad, Telangana, India | |||
| Valentis Laboratories Private Limitedthis company | ₹160.96 Cr (FY 2025) | ₹4.03 Cr | 2.5% | 135.0% | 108 | Sangareddy, Telangana, India |
| Everest Organics Limited | ₹160.17 Cr (FY 2025) | -19.0% | Medak, Telangana, India | |||
| Infinium Pharmachem Limited | ₹157.83 Cr (FY 2025) | 15.0% | Sojitra, Gujarat, India | |||
| Gujarat Themis Biosyn Ltd | ₹153.23 Cr (FY 2025) | -12.0% | Valsad, Gujarat, India | |||
| Allchem Lifescience Limited | ₹152.78 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Valentis Laboratories Private Limited, buy the company report.
Auditor
Valentis Laboratories Private Limited is audited by M M Reddy & co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M M Reddy & co. | FY 2023 | 010371S |
Shareholding
The shareholding of Valentis Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Valentis Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30.64 Cr
Satisfied charges
₹8.99 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2025 | 101085199 | Hdfc Bank Limited | ₹31.22 Lakh | Open | |
| 13 Jan 2025 | 101032336 | Axis Bank Limited | ₹31 Lakh | Open | |
| 06 Jan 2024 | 100848846 | Axis Bank Limited | ₹36.34 Lakh | Open | |
| 30 Jun 2023 | 100775224 | Hdfc Bank Limited | ₹29.99 Lakh | Open | |
| 12 Dec 2022 | 100654613 | Axis Bank Limited | ₹65.73 Lakh | Open |
To see the full charge records of Valentis Laboratories Private Limited, buy the company report.
Total charge records: 15 View all charges
Deals & funding
Valentis Laboratories Private Limited has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹40 Lakh; the latest was in March 2023.
Total deals
10
Secondary share transfers
8
Funding rounds
2
Disclosed funding
₹40 Lakh
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Apr 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: S.R. Drugs and Intermediates Pvt.Ltd. |
To see the full deal history of Valentis Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Valentis Laboratories Private Limited has 51 court cases on record: 25 filed by Valentis Laboratories, 26 filed against it. 30 cases are pending and 21 are disposed.
Total cases
51
Filed by the company
25
Filed against the company
26
Pending
30
Disposed
21
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 25 | 18 | 17 |
| District courts | 13 | 4 | 12 |
| High courts | 7 | 0 | 0 |
| NCLT | 6 | 4 | 1 |
Cases on record (5 of 51)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Insolvency matter | Filed against the company by Manjeera Realty LLP | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Manjeera Realty LLP | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S.Innovare Labs Pvt.Ltd. Rep.By Its Directors and 2 others | Pending |
| NCLT, Hyderabad | Insolvency matter | Filed against the company by M/S. Manjeera Realty LLP (Previously Known As Saasa Villa Llp) | Disposed |
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Alex Construction Private Limited | Disposed |
To see the full case history of Valentis Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Valentis Laboratories Private Limited was last rated by Crisil on 28 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 28 Oct 2020 |
To see the full credit ratings and regulatory alerts of Valentis Laboratories Private Limited, buy the company report.
MSME payment delays
Valentis Laboratories Private Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 181 overdue payments to 63 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 63)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| D.V.Polymers India Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Valentis Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Valentis Laboratories Private Limited has a workforce of 108 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
Employee count
108
Active EPFO establishments
1
Employee growth
8%
GST
Valentis Laboratories has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECS3574Q1ZN | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Valentis Laboratories Private Limited, buy the company report.
Recent activity
Valentis Laboratories Private Limited has 12 board changes on record since 2000: 5 appointments and 7 cessations. The latest: Ravi Teja Prativada ceased to be Additional Director on 29 Sep 2023.
AGM
Valentis Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 24.90 Cr registered on 17 Jun 2019 with Charge ID 100275718 was modified on 28 Apr 2025.
Filing
Valentis Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.31 Cr with Charge ID 101085199 was registered on 15 Mar 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.31 Cr with Charge ID 101032336 was registered on 13 Jan 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.36 Cr with Charge ID 100848846 was registered on 06 Jan 2024.
Ceased
Ravi Teja Prativada ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100775224 was registered on 30 Jun 2023.
Ceased
Jaymalhar Shamrao Mhatre ceased to be Director.
Appointed
Ravi Teja Prativada was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.66 Cr with Charge ID 100654613 was registered on 12 Dec 2022.
Charges
A charge with Axis Bank Limited of Rs. 3.80 Cr registered on 17 Aug 2020 with Charge ID 100364777 was modified on 16 Feb 2022.
30 earlier events are in the company report.
Frequently asked questions
Valentis Laboratories is an active private limited company based in Sangareddy, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 May 1999 (27+ years old) and is registered under CIN U24110TG1999PTC031736.
Valentis Laboratories has 5 current directors:
- Sriramakrishna Durgaprasad Pratiwada - Managing Director
- Devarapu Phani Deep - Director
- Ravi Teja Prativada - Director
- Pratiwada Venkata Chaitanya Prasad - Director
- Partiwada Roja Rani - Director
The latest financial statements of Valentis Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Valentis Laboratories is 36AAECS3574Q1ZN, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Valentis Laboratories is U24110TG1999PTC031736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Valentis Laboratories has 51 court cases on record: 25 filed by the company and 26 filed against it. 30 are pending. Most are in the nclat.
Valentis Laboratories was incorporated on 19 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.
Valentis Laboratories has 10 deals on record (8 secondary share transfers, 2 funding rounds), with disclosed funding of ₹40 Lakh; the latest was in March 2023.
The peers of Valentis Laboratories by revenue are Calyx Chemicals and Pharmaceuticals Limited, S.V. Labs Private Limited, Vasista Life Sciences Private Limited, Syntho Chirals Private Limited, Vivin Drugs & Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravi Teja Prativada ceased to be Additional Director on 29 Sep 2023. Jaymalhar Shamrao Mhatre ceased to be Director on 14 Mar 2023. Ravi Teja Prativada was appointed as Director on 14 Mar 2023. Valentis Laboratories has 12 board changes on record in total.
Yes, Valentis Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-25-0002375).
Valentis Laboratories has 6 MSME Form 1 returns on record between 2019 and 2022, listing 181 overdue payments to 63 micro and small suppliers. The latest return was filed on 30 Apr 2022.